TrialJAMA network open2025

Albuminuria Responses to Dapagliflozin in Patients With Type 2 Diabetes: A Crossover Trial.

Jelle M Beernink et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.